Newsletter | September 3, 2024

09.03.24 -- Is Your Lab Ready For A LIMS Implementation?

FEATURED EDITORIAL

Is Your Lab Ready For A LIMS Implementation?

Deploying a laboratory information management system (LIMS) can boost your quality control lab's productivity, but how are you going about it? This article shares key steps and considerations for setting up your physical lab, controlling inventory, and more.

INDUSTRY INSIGHTS

Biopharma's Talent Crunch: How To Gain And Retain Skilled Labor

What strategies should your company consider for recruiting, training, and retaining qualified candidates in order to remain competitive in a burgeoning biopharma market?

Solid Tumors: The Next Frontier Of Cancer Immunotherapy

With the use of advanced in vitro models like Organ-Chips, researchers are gaining a better understanding of CAR T-cell therapy in the context of solid tumors.

End-To-End Cold Chain Management: A Next-Generation Approach

Three experts in cold chain management walk through the advantages of end-to-end platforms for bulk drug substance management.

Advanced Analytical Tools To De-Risk Pharmaceutical Development

Discover three tools that facilitate a successful journey from candidate compound to clinical triumph: solid form screening, PBPK modeling, and AI-enabled route scouting.

Lung Cancer Treatment By Inhaled Formulations

Explore the formulation and manufacturing of a topotecan inhaled dry powder and its use in decreasing tumor size in an animal model.

MOST POPULAR NEWS

SciSparc Submitted IND App To The FDA For SCI-110 For The Treatment Of Tourette Syndrome

NVIDIA & Global Partners Launch NIM Agent Blueprints For Enterprises To Make Their Own AI

New Way To Potentially Slow Cancer Growth

Invenra's Novel Antibody INV724 Receives RPDD And ODD From The US FDA

Bridge Biotherapeutics & HitGen Initiate Research Collaboration

This Technique For Studying Cell Receptors Could Have Sweeping Implications

Oblique Therapeutics Collaborates With Eli Lilly & Company To Apply The AbiProt Tech

Telix Submits NDA For TLX101-CDx (Pixclara) Brain Cancer Imaging Agent

BeiGene's BGB-16673 Receives U.S. FDA Fast Track Designation For CLL/SLL

Find Therapeutics Announces FDA Clearance Of IND App For A Phase 1 Study Of FTX-101

Flagship Pioneering & Quotient Therapeutics Announce 2 Research Programs Under Strategic Partnership With Pfizer

SOLUTIONS

NanoAssemblr GMP System: Power To Commercialize

Addressing Key TIL Therapy Manufacturing Workflow Challenges